Eledon Pharmaceuticals (ELDN) Other financing activities (2013 - 2021)
Eledon Pharmaceuticals posted quarterly Other financing activities of $450000.0 for Q1 2021, down 66.17% on a QoQ basis from $1.3 million in Q4 2014.
Eledon Pharmaceuticals (ELDN) has 3 years of Other financing activities data on file, last reported at $450000.0 in Q1 2021.
- For the quarter ending Q1 2021, Other financing activities changed N/A year-over-year to $450000.0; the trailing twelve-month figure through Dec 2021 stood at $450000.0 (changed N/A YoY), and the FY2021 full-year result was $450000.0, changed N/A from the prior year.
- Other financing activities for Q1 2021 stood at $450000.0, down from $1.3 million in the prior quarter.
- Across five years, Other financing activities topped out at $450000.0 in Q1 2021 and bottomed at $450000.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 450,000.00 |
| Mar 31, 2021 | 450,000.00 |
| Dec 31, 2014 | 1.33 Mn |
| Dec 31, 2014 | 1.33 Mn |
| Sep 30, 2014 | 1.50 Mn |
| Sep 30, 2014 | 1.50 Mn |
| Dec 31, 2013 | 20,000.00 |
| Dec 31, 2013 | 20,000.00 |